Jack R. Kalin

530 total citations
24 papers, 445 citations indexed

About

Jack R. Kalin is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Jack R. Kalin has authored 24 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Genetics. Recurrent topics in Jack R. Kalin's work include Retinoids in leukemia and cellular processes (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Estrogen and related hormone effects (4 papers). Jack R. Kalin is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Estrogen and related hormone effects (4 papers). Jack R. Kalin collaborates with scholars based in United States, United Kingdom and Greece. Jack R. Kalin's co-authors include Donald L. Hill, Charles M. Allen, Jonathan Sack, M. J. Wells, Dirck L. Dillehay, Wei Li, E W Lamon, Alan J. Lee, James W. Barnett and John A. Montgomery and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Jack R. Kalin

24 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack R. Kalin United States 13 250 81 64 51 40 24 445
Janice M. Larner United States 16 195 0.8× 108 1.3× 48 0.8× 353 6.9× 37 0.9× 25 706
Tomoyuki Shirai Japan 12 215 0.9× 34 0.4× 29 0.5× 61 1.2× 110 2.8× 22 569
John L. Seed United States 14 278 1.1× 123 1.5× 28 0.4× 19 0.4× 189 4.7× 25 697
J. Schneider Germany 11 159 0.6× 24 0.3× 37 0.6× 34 0.7× 11 0.3× 32 518
Elisabeth Barofsky United States 13 339 1.4× 98 1.2× 56 0.9× 39 0.8× 24 0.6× 22 739
Hanan Osman‐Ponchet France 12 217 0.9× 24 0.3× 19 0.3× 41 0.8× 9 0.2× 32 621
N. de Vogel Netherlands 15 381 1.5× 126 1.6× 22 0.3× 47 0.9× 381 9.5× 29 716
M. Csató Hungary 11 156 0.6× 31 0.4× 9 0.1× 11 0.2× 23 0.6× 28 495
PS Shirley United States 9 246 1.0× 27 0.3× 17 0.3× 27 0.5× 28 0.7× 12 576
Mengrong Li China 11 238 1.0× 10 0.1× 17 0.3× 80 1.6× 21 0.5× 36 482

Countries citing papers authored by Jack R. Kalin

Since Specialization
Citations

This map shows the geographic impact of Jack R. Kalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack R. Kalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack R. Kalin more than expected).

Fields of papers citing papers by Jack R. Kalin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack R. Kalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack R. Kalin. The network helps show where Jack R. Kalin may publish in the future.

Co-authorship network of co-authors of Jack R. Kalin

This figure shows the co-authorship network connecting the top 25 collaborators of Jack R. Kalin. A scholar is included among the top collaborators of Jack R. Kalin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack R. Kalin. Jack R. Kalin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Matthew I., Agni Orfanoudaki, Michael Cronin, et al.. (2022). Natural Language Processing of Radiology Reports to Detect Complications of Ischemic Stroke. Neurocritical Care. 37(S2). 291–302. 14 indexed citations
2.
Shealy, Y. Fulmer, James M. Riordan, Donald L. Hill, et al.. (1997). Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.. PubMed. 12(1). 15–33. 1 indexed citations
3.
Kalin, Jack R., et al.. (1994). A Possible Suicide by Diltiazem Overdose. Journal of Analytical Toxicology. 18(3). 180–182. 12 indexed citations
4.
Kalin, Jack R., et al.. (1989). Disposition of 2′, 3′-dideoxyadenosine and 2′, 3′-dideoxyinosine in mice. Investigational New Drugs. 7(2-3). 139–146. 10 indexed citations
5.
Kalin, Jack R., et al.. (1989). Disposition of 2‐mercaptobenzothia2ole and 2‐mercaptobenzothiazole disulfide in rats dosed intravenously, orally, and topically and in guinea pigs dosed topically. Journal of Toxicology and Environmental Health. 27(1). 65–84. 15 indexed citations
6.
Kalin, Jack R. & Donald L. Hill. (1988). Determination of 2′,3′-dideoxyadenosine, 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine in biological samples. Journal of Chromatography B Biomedical Sciences and Applications. 431(1). 184–191. 18 indexed citations
7.
Kalin, Jack R., et al.. (1988). Disposition of 2‐(2‐quinolyl)‐1,3‐indandione (d. c. yellow #11) in rats dosed orally or intravenously. Journal of Toxicology and Environmental Health. 23(3). 385–393. 2 indexed citations
8.
Kalin, Jack R., et al.. (1987). Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding. Journal of Toxicology and Environmental Health. 22(4). 405–415. 50 indexed citations
10.
Noker, P. E., et al.. (1986). Disposition of sucrose octa-isobutyrate in rats, dogs and monkeys. Food and Chemical Toxicology. 24(12). 1287–1293. 7 indexed citations
11.
Kalin, Jack R., et al.. (1986). Disposition of 2‐hydroxy‐4‐methoxybenzophenone in rats dosed orally, intravenously, or topically. Journal of Toxicology and Environmental Health. 19(4). 491–502. 25 indexed citations
12.
Kalin, Jack R., et al.. (1985). Disposition of 9‐aminoacridine in rats dosed orally or intravenously and in monkeys dosed topically. Journal of Toxicology and Environmental Health. 15(6). 789–799. 1 indexed citations
13.
Noker, P. E., et al.. (1985). PHARMACOKINETIC AND METABOLISM STUDIES OF TWO NOVEL 1-DEAZA-7,8-DIHYDROPTERIDINES IN MICE. Drug Metabolism and Disposition. 13(6). 677–681. 1 indexed citations
14.
Kalin, Jack R., M. J. Wells, & Donald L. Hill. (1984). Effects of phenobarbital, 3-methylcholanthrene, and retinoid pretreatment on disposition of orally administered retinoids in mice.. Drug Metabolism and Disposition. 12(1). 63–67. 20 indexed citations
15.
Kalin, Jack R., et al.. (1984). Disposition of 2‐mercaptobenzimidazole in rats dosed orally or intravenously. Journal of Toxicology and Environmental Health. 14(4). 595–604. 7 indexed citations
16.
Hill, Donald L., et al.. (1981). DISPOSITION OF ORALLY ADMINISTERED 13‐cis RETINOIC ACID IN MICE. Annals of the New York Academy of Sciences. 359(1). 396–397. 1 indexed citations
17.
Kalin, Jack R., et al.. (1981). Disposition of all-trans-retinoic acid in mice following oral doses.. Drug Metabolism and Disposition. 9(3). 196–201. 44 indexed citations
18.
Kalin, Jack R. & Charles M. Allen. (1980). Lipid activation of undecaprenol kinase from Lactobacillus plantarum. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 619(1). 76–89. 7 indexed citations
19.
Kalin, Jack R. & Charles M. Allen. (1979). Characterization of undecaprenol kinase from Lactobacillus plantarum. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 574(1). 112–122. 24 indexed citations
20.
Allen, Charles M., et al.. (1978). CTP-dependent dolichol phosphorylation by mammalian cell homogenates. Biochemistry. 17(23). 5020–5026. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026